Abbott Laboratories (ABT) (JOBS) Completes Acquisition of Evalve, Inc.
11/2/2009 6:26:43 AM
More...
|
Evalve, Inc.: MitraClip(R) Therapy Data Demonstrate Significant Left Ventricular Reverse Remodeling in Patients With Sustained Reduction of Mitral Regurgitation
9/23/2009 10:21:58 AM
More...
|
Evalve, Inc. Ongoing Progress of MitraClip(R) Therapy Highlighted at TCT 2009
9/15/2009 10:37:43 AM
More...
|
Abbott Laboratories (ABT) (JOBS) To Buy Heart-Valve Repair Company Evalve, Inc. For Up To $410 Million
9/11/2009 6:53:31 AM
More...
|
Evalve, Inc.: MitraClip(R) Therapy Introduced in Austria
9/10/2009 9:54:14 AM
More...
|
Evalve, Inc.: First Swedish Patients Receive MitraClip(R) Therapy
8/25/2009 11:42:24 AM
More...
|
Evalve, Inc. MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation
5/20/2009 10:45:01 AM
More...
|
Evalve, Inc.: First 100 Patients Treated in Europe with the MitraClip(R) System for Percutaneous Mitral Repair
5/15/2009 9:08:14 AM
More...
|
Evalve, Inc. Release: First Patients Enrolled in the Access-Europe Study of The MitraClip(R) Therapy
4/6/2009 9:58:57 AM
More...
|
Evalve, Inc. Release: MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up
3/29/2009 10:39:31 PM
More...
|
|